Company

About

cGMPnow

cGMPnow

Boulder, Colorado, United States

cGMPnow accelerates Gene & Cell Therapy products to patients by providing GMP Manufacturing & QC Laboratory Equipment, Automation & Controls (IT/OT), Commissioning & Qualification, and Procurement services using project-dedicated expert resources.

Colorado State University

Colorado State University

Fort Collins, Colorado, US

Colorado State University is a Higher Education institution that offers a variety of academic programs and conducts research in various fields.

Greffex

Greffex

12635 E. Montview Blvd. Suite 280, Aurora, Colorado 80045, US

Greffex™ is a privately held, multi-national company, headquartered in Aurora, Colorado. Established in 1999, Greffex has developed a novel genetic platform for the development and production of vaccines. Our proprietary GREVAX™ Universal Platform delivers vaccines in a faster, more affordable and more efficient manner. Once a pathogen has been identified, Greffex's team designs and produces a GREVAX™ vaccine in as little as 4 weeks. The state-of-the-art flexibility of the GREVAX™ Universal Platform makes it the ideal delivery vehicle for vaccines against a wide variety of infectious disease, including but not limited to Pandemic Influenza strains, Anthrax and Dengue Fever, as well as Malaria, Hepatitis C, Respiratory Syncytial Virus (RSV), Ebola, HPV, Plague, Tuberculosis and a host of other vaccine candidates.

InVitria

InVitria

Aurora, Colorado, United States

RheumaGen

RheumaGen

Denver, Colorado

RheumaGen is the only cell and gene therapy company editing the HLA gene to cure autoimmune diseases at their source.

S. M. Discovery Group

S. M. Discovery Group

littleton, co, united states

Delivering life changing & first-in-class therapies to patients suffering from debilitating diseases #Science #GeneTherapy #Biotechnology #Medicine #Innovation

Terumo Blood and Cell Technologies

Terumo Blood and Cell Technologies

Lakewood, Colorado, United States

Headquartered in Lakewood, Colorado, Terumo Blood and Cell Technologies provides blood component, therapeutic apheresis and cellular technologies serving customers in more than 130 countries.